Alnylam CEO Yvonne Greenstreet got an $18M equity award tied to performance through 2029 after the drugmaker's first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results